King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation

Movement Disorders

Volumn 30, Issue 12, 2015, Pages 1623-1631

  Chaudhuri, K Ray ^a,b,c   Rizos, Alexandra ^a   Trenkwalder, C ^d   Rascol, O ^e   Pal, S ^f   Martino, D ^g   Carroll, C ^h   Paviour, D ⁱ   Falup Pecurariu, C ^j   Kessel, B ^a   Silverdale, M ^k   Todorova, A ^a   Sauerbier, A ^a   Odin, P ^l,m   Antonini, A ⁿ   Martinez Martin, P ^o  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

^d Paracelsus Elena Hospital   (Germany)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

^g LEWISHAM AND GREENWICH NHS TRUST   (United Kingdom)

^h PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

ⁱ ST GEORGE S HOSPITAL   (United Kingdom)

^j TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^k Greater Manchester Neurosciences Centre   (United Kingdom)

^l LUND UNIVERSITY   (Sweden)

^m Klinikum Bremerhaven Reinkenheide   (Germany)

ⁿ IRCCS SAN CAMILLO HOSPITAL   (Italy)

^o INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

Pain; Parkinson's disease; Scale

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRONBACH ALPHA COEFFICIENT; FEMALE; GENDER; HUMAN; KING PARKINSON DISEASE PAIN SCALE; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; VALIDATION STUDY; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; NONPARAMETRIC TEST; PAIN MEASUREMENT; PSYCHOLOGICAL RATING SCALE; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84944514335     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26270     Document Type: Article

References (39)

1. Chaudhuri KR, Healy D, Schapira AHV. The non motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
2. Chaudhuri KR, Schapira AHV. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.
3. Parkinson J. An Essay on the Shaking Palsy. Whittingham and Rowland, London, 1817.
4. Ford, B. Pain in Parkinson's disease. Mov Disord 2010;25(Suppl 1):S98-S103.
5. Wasner G, Deuschl G. Pains in Parkinson disease: many syndromes under one umbrella. Nat Rev Neurol 2012;8:284-294.
6. Ha AD, Jankovic J. Pain in Parkinson's disease. Mov Disord 2012;27:485-491.
7. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The non declaration of non motor symptoms of Parkinson's disease to health care professionals: an international study using the non motor symptoms questionnaire. Mov Disord 2010;25:704-709.
8. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22:1901-1911.
9. Sivam D, Rizos A, Martin A, et al. Pain in Parkinson's disease: observational study of 225 patients. Mov Disord 2011:26(Suppl 2):Abs No: 536.
10. Negre-Pages L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov Disord 2008;23:1361-1369.
11. 2 laser-evoked potentials. Mov Disord 2010;25:213-220.
12. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
13. Marinus J, Visser M, Stiggelbout AM, et al. A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA. J Neurol Neurosurg Psychiatry 2004;75:388-395.
14. Martinez-Martin P, Benito-Leon J, Burguera JA, et al. The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure. J Clin Epidemiol 2005;58:674-679.
15. Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, de Pedro J, on behalf of the Spanish-American Longitudinal PD Patient Study Group. The Clinical Impression of Severity Index for Parkinson's disease: international validation study. Mov Disord 2009;24:211-217.
16. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
17. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
18. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The PDQ-8: development and validation of a short-form Parkinson's disease questionnaire. Psychology & Health 1997;12:805-814.
19. Trenkwalder C, Kohnen K, Högl B, et al. Parkinson Disease Sleep Scale: validation of the Revised Version PDSS-2. Mov Disord 2011;26:644-652.
20. Martinez-Martin P, Tolosa E, Hernandez B, Badia X. Validation of the "QUICK" questionnaire: a tool for diagnosis of "wearing-off" in patients with Parkinsons disease. Mov Disord 2008;23:830-836.
21. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment, 2nd ed. New York: Guilford Press, 2001, pp 15-34.
22. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
23. Smith SC, Lamping DL, Banarjee S, et al. Measurement of health- related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess 2005;9:16-19.
24. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995;4:293-307.
25. Hays RD, Anderson R, Revicki D. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 1993;2:441-449.
26. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002;11:193-205.
27. Streiner DL, Norman GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 4th ed. Oxford: Oxford University Press, 2008, p 87.
28. Clark LA, Watson D. Constructing validity: basic issues in objective scale development. Psychol Assess 1995;7:309-319.
29. Beavers AS, Lounsbury JW, Richards JK, Huck SW, Skolits GJ, Esquivel SL. Practical considerations for using exploratory factor analysis in educational research. Practical Assessment Research & Evaluation 2013;18:6.
30. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers, 1996;49-56.
31. Terwee C, Bot SDM, de Boer RM, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34-42.
32. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995;57:289-300.
33. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
34. Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson's disease: a controlled cross-sectional study. Parkinsonism Relat Disord 2004;10:129-136.
35. Cury RG, Galhardoni R, Fonoff ET, et al. Effects of deep brain stimulation on pain and other nonmotor symptoms in Parkinson disease. Neurology 2014;83:1403-1409.
36. Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson's disease. Clin Neurol Neurosurg 2011;113:11-13.
37. Martinez-Martin P, Falup Pecurariu C, Odin P, et al. Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol 2012;259:1639-1647.
38. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care 2003;41:582-592.
39. Wyrwich KW, Bullinger M, Aaronson N, Hays RD, Patrick DL, Symonds T. The Clinical Significance Consensus Meeting Group: estimating clinically significant differences in quality of life outcomes. Qual Life Res 2005;14:285-295.